573 related articles for article (PubMed ID: 10403463)
21. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma.
Charous SJ; Stricklin GP; Nanney LB; Netterville JL; Burkey BB
Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):271-8. PubMed ID: 9109715
[TBL] [Abstract][Full Text] [Related]
22. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
23. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status.
Mäkelä M; Salo T; Uitto VJ; Larjava H
J Dent Res; 1994 Aug; 73(8):1397-406. PubMed ID: 8083435
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha.
Rawdanowicz TJ; Hampton AL; Nagase H; Woolley DE; Salamonsen LA
J Clin Endocrinol Metab; 1994 Aug; 79(2):530-6. PubMed ID: 8045973
[TBL] [Abstract][Full Text] [Related]
26. Expression of matrix metalloproteinase-2 and -9 during early human wound healing.
Salo T; Mäkelä M; Kylmäniemi M; Autio-Harmainen H; Larjava H
Lab Invest; 1994 Feb; 70(2):176-82. PubMed ID: 8139259
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
28. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
[TBL] [Abstract][Full Text] [Related]
30. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
Kawamata H; Nakashiro K; Uchida D; Harada K; Yoshida H; Sato M
Int J Cancer; 1997 Jan; 70(1):120-7. PubMed ID: 8985100
[TBL] [Abstract][Full Text] [Related]
31. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
Fishman DA; Bafetti LM; Stack MS
Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.
Meade-Tollin LC; Boukamp P; Fusenig NE; Bowen CP; Tsang TC; Bowden GT
Br J Cancer; 1998 Mar; 77(5):724-30. PubMed ID: 9514050
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.
Rankin CA; Suzuki K; Itoh Y; Ziemer DM; Grantham JJ; Calvet JP; Nagase H
Kidney Int; 1996 Sep; 50(3):835-44. PubMed ID: 8872958
[TBL] [Abstract][Full Text] [Related]
35. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
Zeng ZS; Cohen AM; Guillem JG
Carcinogenesis; 1999 May; 20(5):749-55. PubMed ID: 10334190
[TBL] [Abstract][Full Text] [Related]
36. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Nakagawa H; Yagihashi S
Jpn J Cancer Res; 1994 Sep; 85(9):934-8. PubMed ID: 7961122
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
[TBL] [Abstract][Full Text] [Related]
38. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.
Rao VH; Bridge JA; Neff JR; Schaefer GB; Buehler BA; Vishwanatha JK; Pollock RE; Nicolson GL; Yamamoto M; Gokaslam ZL
Clin Exp Metastasis; 1995 Nov; 13(6):420-6. PubMed ID: 7586800
[TBL] [Abstract][Full Text] [Related]
39. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential.
Sreenath T; Matrisian LM; Stetler-Stevenson W; Gattoni-Celli S; Pozzatti RO
Cancer Res; 1992 Sep; 52(18):4942-7. PubMed ID: 1325287
[TBL] [Abstract][Full Text] [Related]
40. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization.
Miyajima Y; Nakano R; Morimatsu M
Ann Otol Rhinol Laryngol; 1995 Sep; 104(9 Pt 1):678-84. PubMed ID: 7661515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
